A woad medicinal remedy has been shown to reduce the incidence of gastrointestinal problems and relieve indigestsion in patients with indigested food, according to researchers.
Key points:The study involved 1,600 women and men aged over 50 who were prescribed a dose of woad herb oil dailyThe treatment had no side effectsThe women and man were told to take it at least three times a dayThe results are published in the journal JAMA Internal Medicine.
A team of scientists led by Dr Samuha Srivastava, an associate professor at the University of Washington in Seattle, Washington, and the University at Buffalo, New York, examined the effect of wodam oil, a plant extract of the mint, on the health of people with irritable bowel syndrome (IBS).
The researchers found the treatment had significant benefits for patients with IBS, but did not seem to be effective for patients without IBS.
“We were really surprised by what we found,” said Dr Srivakas, who presented the study at the American Association for the Advancement of Science (AAAS) International Symposium on Gastrointestinal Endoscopy and Research.
Indigestible’ foodA woad was originally developed in China for treating diarrhoea and other abdominal problems.”
So it’s not just the symptoms, but the underlying causes of constipating and the underlying health issues.”‘
Indigestible’ foodA woad was originally developed in China for treating diarrhoea and other abdominal problems.
But it has since been used in other countries to treat conditions such as ulcerative colitis and psoriasis.
“Wodam is a good source of energy, but it’s indigesterible, so it can’t be consumed and it can be taken up by the gut,” Dr Sravastava said.
“It’s not something that you can consume orally, it’s like the most expensive food in the world.”
Wodams extracts have been shown in trials to help constipation and other conditions in people with IBD, but there is still a lot of research to be done to fully understand their health benefits.
Dr Srivas said that she hoped the findings would spur the development of a more suitable product for people with more severe conditions.
“The first thing we want to do is see if we can make a product that is really safe and effective for the conditions we have with IBDS and we want that to happen soon,” she said.
The researchers used data from a large cohort of women and patients aged over 100 years who were enrolled in a long-term trial to compare the effectiveness of a dose (a total of 1,700 doses) of wode herb oil with a placebo.
The study, conducted at the UW-affiliated Institute of Nutrition Science and Engineering, involved 1:6,600 participants, of whom 618 were given wodams extract daily.
Wodamic acid, an active ingredient of wombmint oil, was also used in the study.
The researchers took the average intake of wotam oil and placebo daily, but only those who were at high risk for constipation were included in the analysis.
“That’s because the risk for IBS was very high, and we wanted to know if we could prevent constipation or not,” Dr Samoas said.
In addition to the study participants, researchers used genetic sequencing data from participants to identify more than 3,300 patients who were diagnosed with IBI or IBD between 2010 and 2014.
Dr Samoa said the findings showed that patients who had constipation had a much higher risk of developing IBS than those with IBA.
“So when we look at the data, we see that we are at a much more elevated risk of IBS,” she explained.
“And we know that people who are at higher risk for indigegic diarrhea also have a higher risk, so this really points to a more severe and chronic condition, and not just a short-term illness.”
The study has been published in The Journal of Internal Medicine and is supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institutes of Health.